Obermatt
See Similar Stocks →

IRadimed

NMQ:IRMD · US46266A1097
Health Care Equipment & SuppliesSmall

360

64
Medium confidence — indicative
EV / EBIT7
Price / Owner Earnings15
Owner Earnings Yield65
Dividend Yield1
Price/Sales7
EV / Gross Profit9
Price/Book13
Return on Capital100
Cash Return on Capital100
Return on Equity95
EBIT Margin100
Gross Profitability80
Cash Conversion21
Accruals47
Owner Earnings Margin98
Sales growth53
Profit Growth52
Long-Term EPS Growth34
Owner Earnings Growth85
Reinvestment67
Price momentum98
Debt load65
Refinancing18
Debt Payback100
Liquidity1
Analyst ratings100
Opinion Changes3
Price Target Upside32
Market mood56
Value Creation20/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

IRadimed generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded1992
Employees128
Websiteiradimed.com
ISINUS46266A1097
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)D.J. US Medical Equipment
Themes
Health DiagnosticsSensorsBiomedical EngineeringDetectors, Sensors and MemsService Industry

Description

IRADIMED CORPORATION (IRadimed) develops, manufactures, markets and distributes Magnetic Resonance Imaging (‘MRI’) compatible medical devices and related accessories, disposables and services relating to them. MRidium 3860+ MRI Compatible IV Infusio…

Analysis

Beloved champion

IRADIMED CORPORATION sits in the top corner of our grid: excellent business, premium price; every investor already knows the story. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is expensive. The owner-earnings multiple stands at 59.7×; owner earnings: the cash an owner could take out each year.

Growth is solid; the safety picture is uncertain. The company scores 20/20 on our value-creation score: strong value creator.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
48
2023202420252026

All-time high

82

Jan 2023

All-time low

48

Mar 2026

Average rank

65

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
7
9
10
15
Price/Earnings
12
24
17
21
Price/Book
13
25
12
26
Dividend Yield
1
92
94
1
Value (overall)
1
45
31
9

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare IRadimed with its peers
Baxter
NYQ:BAX
2
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Dexcom
NSQ:DXCM
92
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Hyperfine
NMQ:HYPR
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SS Innovations International
NAQ:SSII
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
KORU Medical Systems
NAQ:KRMD
40
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Fonar
NAQ:FONR
53
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →